Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Sapporo »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Sapporo < Sapporo < Sapporo 060-0815  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
001122 (2018) M. Kono [Japon] ; S. Yasuda [Japon] ; M. Kono [Japon] ; T. Atsumi [Japon]Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.
001185 (2018) Shun Tanimura [Japon] ; Masaru Kato [Japon] ; Nobuya Abe [Japon] ; Hiroshi Ohira [Japon] ; Ichizo Tsujino [Japon] ; Tatsuya Atsumi [Japon]Successful treatment of tocilizumab-resistant large vessel pulmonary arteritis with infliximab.
001213 (2018) Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon]Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.
001247 (2018) Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon]Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database.
001377 (2018) H. Nihira [Japon] ; K. Nakagawa [Japon] ; K. Izawa [Japon] ; T. Kawai [Japon] ; T. Yasumi [Japon] ; R. Nishikomori [Japon] ; M. Nambu [Japon] ; A. Miyagawa-Hayashino [Japon] ; T. Nomura [Japon] ; K. Kabashima [Japon] ; M. Ito [Japon] ; S. Iwaki-Egawa [Japon] ; Y. Sasahara [Japon] ; M. Nakayama [Japon] ; T. Heike [Japon]Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency.
001833 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Sapporo " 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Sapporo " \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Sapporo 
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021